Clearline Capital’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,228
Closed -$948K 109
2024
Q3
$948K Sell
21,228
-14,622
-41% -$605K 0.04% 117
2024
Q2
$1.38M Sell
35,850
-295,432
-89% -$11.3M 0.04% 107
2024
Q1
$11.4M Sell
331,282
-235,582
-42% -$7.56M 0.56% 29
2023
Q4
$16.4M Sell
566,864
-203,660
-26% -$4.64M 1.01% 20
2023
Q3
$14.6M Buy
+770,524
New +$14.6M 1.25% 23

Other funds holding DBD

Clearline Capital's DBD Position: Q4 2024 in Review

Clearline Capital sold out of Diebold Nixdorf (DBD) in Q4 2024, closing a stake of 21,228 shares — an estimated $948K sold.

Clearline Capital first reported a position in DBD in Q3 2023 and held it in 5 quarters. The position peaked at $16.4M in Q4 2023. 130 funds tracked by Wall St. Rank hold DBD as of Q4 2024.

  • Clearline Capital reported no remaining Diebold Nixdorf position as of Q4 2024 after selling out during the quarter.
  • Clearline Capital sold 21,228 Diebold Nixdorf shares in Q4 2024, an estimated $948K.
  • Clearline Capital first reported a position in Diebold Nixdorf in Q3 2023 and held it in 5 quarters.
  • Clearline Capital's Diebold Nixdorf position peaked at $16.4M in Q4 2023.
  • 130 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.